← All indications
Fecal Incontinence
Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.
Drugs by status
Approved for this indication (2)
Phase 4 trials (3)
Phase 3 trials (13)
Phase 2 trials (6)
Phase 1 trials (7)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (16)
- National Institutes of Health (NIH)
- University of Pennsylvania
- University of Pittsburgh
- Brown University
- University of London
- Duke University
- RTI International
- University of New Mexico
- University of Rochester
- Mayo Clinic
- University of California, San Diego
- SLA Pharma
- University of Alabama, Birmingham
- Department of Veteran Affairs
- Rouen Normandy University
- National Institute of Child Health and Human Development (NICHD)
Organization Involved with Phase 2 Indications (12)
- Allergan
- Norgine
- RDD Pharma Ltd
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Andalusian Initiative for Advanced Therapies
- University of Seville
- University of North Carolina at Chapel Hill
- Consortium of Multiple Sclerosis Centers
- Andalusian Initiative in Advanced Therapies
- University of Rennes
- Cook Medical
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (5)